Industry / Israel
BMI Revises Pharmaceutical Market Size
May 2011 | Industry Trend AnalysisBMI View: Israel claims to have a very efficient healthcare system that means it does not need to spend as much of its GDP on healthcare. In truth, the government's fiscal austerity and sick funds keep the most expensive innovative drugs unavailable, while cheaper generics help to control overall cost. Furthermore, private Israeli hospitals are run more efficiently than many other state-funded
To read the full article, please choose one of the following options:
Subcribers please log in




